These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

942 related items for PubMed ID: 15518753

  • 1. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
    Kim HC, Hwang EA, Han SY, Park SB, Kim HT, Cho WH.
    Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 3. Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.
    Boots JM, van Duijnhoven EM, Christiaans MH, Nieman FH, van Suylen RJ, van Hooff JP.
    Transpl Int; 2001 Dec; 14(6):370-83. PubMed ID: 11793034
    [Abstract] [Full Text] [Related]

  • 4. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M, Pellegrini C, Martinelli L, Goggi C, Gavazzi A, Campana C, Arbustini E, Grossi P, Regazzi M, Ippoliti G, Vigano M.
    J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
    [Abstract] [Full Text] [Related]

  • 5. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in primary SPK transplantation: 3-year results of the Euro-SPK 001 trial.
    Saudek F, Malaise J, Boucek P, Adamec M, Euro-SPK Study Group.
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii3-10, ii62. PubMed ID: 15814547
    [Abstract] [Full Text] [Related]

  • 7. Long-term graft function with tacrolimus and cyclosporine in renal transplantation: paired kidney analysis.
    Cheung CY, Chan HW, Liu YL, Chau KF, Li CS.
    Nephrology (Carlton); 2009 Dec; 14(8):758-63. PubMed ID: 20025685
    [Abstract] [Full Text] [Related]

  • 8. Rejection after simultaneous pancreas-kidney transplantation.
    Arbogast H, Malaise J, Illner WD, Tarabichi A, Dieterle C, Landgraf R, Land W, Euro-SPK Study Group.
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
    [Abstract] [Full Text] [Related]

  • 9. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation.
    Barone GW, Ketel BL, Abul-Ezz SR, Lightfoot ML.
    JOP; 2002 Mar; 3(2):49-53. PubMed ID: 11884766
    [Abstract] [Full Text] [Related]

  • 10. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.
    Kobashigawa JA, Patel J, Furukawa H, Moriguchi JD, Yeatman L, Takemoto S, Marquez A, Shaw J, Oeser BT, Subherwal S, Wu GW, Kawano J, Laks H.
    J Heart Lung Transplant; 2006 Apr; 25(4):434-9. PubMed ID: 16563974
    [Abstract] [Full Text] [Related]

  • 11. Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.
    Gnatta D, Keitel E, Heineck I, Cardoso BD, Rodrigues AP, Michel K, Garcia VD.
    Transplant Proc; 2010 Mar; 42(2):475-8. PubMed ID: 20304169
    [Abstract] [Full Text] [Related]

  • 12. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B.
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [Abstract] [Full Text] [Related]

  • 13. Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis.
    Fan Y, Xiao YB, Weng YG.
    Transplant Proc; 2009 Jun; 41(5):1821-4. PubMed ID: 19545736
    [Abstract] [Full Text] [Related]

  • 14. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.
    McDiarmid SV, Busuttil RW, Ascher NL, Burdick J, D'Alessandro AM, Esquivel C, Kalayoglu M, Klein AS, Marsh JW, Miller CM.
    Transplantation; 1995 Feb 27; 59(4):530-6. PubMed ID: 7533345
    [Abstract] [Full Text] [Related]

  • 15. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation.
    Trompeter R, Filler G, Webb NJ, Watson AR, Milford DV, Tyden G, Grenda R, Janda J, Hughes D, Ehrich JH, Klare B, Zacchello G, Bjorn Brekke I, McGraw M, Perner F, Ghio L, Balzar E, Friman S, Gusmano R, Stolpe J.
    Pediatr Nephrol; 2002 Mar 27; 17(3):141-9. PubMed ID: 11956848
    [Abstract] [Full Text] [Related]

  • 16. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
    Filler G, Webb NJ, Milford DV, Watson AR, Gellermann J, Tyden G, Grenda R, Vondrak K, Hughes D, Offner G, Griebel M, Brekke IB, McGraw M, Balzar E, Friman S, Trompeter R.
    Pediatr Transplant; 2005 Aug 27; 9(4):498-503. PubMed ID: 16048603
    [Abstract] [Full Text] [Related]

  • 17. Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure.
    Jevnikar A, Arlen D, Barrett B, Boucher A, Cardella C, Cockfield SM, Rush D, Paraskevas S, Shapiro J, Shoker A, Yilmaz S, Zaltzman JS, Kiberd B.
    Transplantation; 2008 Oct 15; 86(7):953-60. PubMed ID: 18852662
    [Abstract] [Full Text] [Related]

  • 18. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Sobh M, Ghoneim M.
    Saudi J Kidney Dis Transpl; 2008 Jul 15; 19(4):564-70. PubMed ID: 18580014
    [Abstract] [Full Text] [Related]

  • 19. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct 15; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 20. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
    Waid T, CRAF Study Group.
    Clin Transplant; 2005 Oct 15; 19(5):573-80. PubMed ID: 16146546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.